Known Side Effects and Safety Concerns The most common side effects are gastrointestinal (nausea, vomiting, diarrhoea), typically mild to moderate
Approximately 15-40% of individuals diagnosed with IBD and an additional 20-40% are estimated to be obese and overweight respectively ( Table 1 )
Download this guide with insights from our Chief Medical Officer to explore: The true driver behind escalating healthcare costs: obesity A history of GLP-1s and how they work Answers to the question - "Should I cover GLP-1s for my employees who want to lose weight?" with insights from +60 client consultation this year A 5-step plan for a holistic, sustainable approach to weight management
By focusing on these elite strains, Bioma delivers a formulation tailored to address bloating, sluggish digestion, and weight loss barriers at the microbial level
If signs of irritation or sensitivity appear, stop use and consult a specialist
This varies a lot